ReviewActa pharmaceutica Sinica. B2022

Recent development on COX-2 inhibitors as promising anti-inflammatory agents: The past 10 years.

Zhiran Ju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.